Product NDC: | 61703-356 |
Proprietary Name: | Pamidronate Disodium |
Non Proprietary Name: | PAMIDRONATE DISODIUM |
Active Ingredient(s): | 9 mg/mL & nbsp; PAMIDRONATE DISODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-356 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075841 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110623 |
Package NDC: | 61703-356-18 |
Package Description: | 1 VIAL in 1 CARTON (61703-356-18) > 10 mL in 1 VIAL |
NDC Code | 61703-356-18 |
Proprietary Name | Pamidronate Disodium |
Package Description | 1 VIAL in 1 CARTON (61703-356-18) > 10 mL in 1 VIAL |
Product NDC | 61703-356 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PAMIDRONATE DISODIUM |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110623 |
Marketing Category Name | ANDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | PAMIDRONATE DISODIUM |
Strength Number | 9 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |